OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The role of E3 ubiquitin ligase HECTD3 in cancer and beyond
Qiuyun Jiang, Fubing Li, Zhuo Cheng, et al.
Cellular and Molecular Life Sciences (2019) Vol. 77, Iss. 8, pp. 1483-1495
Closed Access | Times Cited: 27
Qiuyun Jiang, Fubing Li, Zhuo Cheng, et al.
Cellular and Molecular Life Sciences (2019) Vol. 77, Iss. 8, pp. 1483-1495
Closed Access | Times Cited: 27
Showing 1-25 of 27 citing articles:
E3 ubiquitin ligases: styles, structures and functions
Quan Yang, Jinyao Zhao, Dan Chen, et al.
Molecular Biomedicine (2021) Vol. 2, Iss. 1
Open Access | Times Cited: 219
Quan Yang, Jinyao Zhao, Dan Chen, et al.
Molecular Biomedicine (2021) Vol. 2, Iss. 1
Open Access | Times Cited: 219
The role of ubiquitination in health and disease
Yan Liao, Wangzheqi Zhang, Yang Liu, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 7
Yan Liao, Wangzheqi Zhang, Yang Liu, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 7
Hypothermic oxygenated perfusion inhibits HECTD3-mediated TRAF3 polyubiquitination to alleviate DCD liver ischemia-reperfusion injury
Wei Zhou, Zibiao Zhong, Danni Lin, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 2
Open Access | Times Cited: 27
Wei Zhou, Zibiao Zhong, Danni Lin, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 2
Open Access | Times Cited: 27
Targeting HECTD3-IKKα axis inhibits inflammation-related metastasis
Fubing Li, Huichun Liang, Hua You, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 21
Fubing Li, Huichun Liang, Hua You, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 21
Portrait of WWP1: the current state in human cancer
Jiaming Lei, Jun Chen, Wenwen Yu, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access
Jiaming Lei, Jun Chen, Wenwen Yu, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access
E3 ubiquitin ligase HECTD3 is a tumor suppressor and mediates the polyubiquitination of SLC7A11 to promote ferroptosis in colon cancer
Fuda Huang, Zihua Huang, Qing Wei, et al.
Experimental Cell Research (2023) Vol. 430, Iss. 1, pp. 113697-113697
Open Access | Times Cited: 9
Fuda Huang, Zihua Huang, Qing Wei, et al.
Experimental Cell Research (2023) Vol. 430, Iss. 1, pp. 113697-113697
Open Access | Times Cited: 9
Targeting ubiquitin conjugating enzyme UbcH5b by a triterpenoid PC3-15 from Schisandra plants sensitizes triple-negative breast cancer cells to lapatinib
Maobo Huang, Yuan‐Fei Zhou, Dongzhu Duan, et al.
Cancer Letters (2021) Vol. 504, pp. 125-136
Closed Access | Times Cited: 22
Maobo Huang, Yuan‐Fei Zhou, Dongzhu Duan, et al.
Cancer Letters (2021) Vol. 504, pp. 125-136
Closed Access | Times Cited: 22
HECTD3 regulates the tumourigenesis of glioblastoma by polyubiquitinating PARP1 and activating EGFR signalling pathway
Guanghui Zhang, Ruoyue Tan, Sicheng Wan, et al.
British Journal of Cancer (2022) Vol. 127, Iss. 11, pp. 1925-1938
Open Access | Times Cited: 15
Guanghui Zhang, Ruoyue Tan, Sicheng Wan, et al.
British Journal of Cancer (2022) Vol. 127, Iss. 11, pp. 1925-1938
Open Access | Times Cited: 15
Regulation of apoptosis by ubiquitination in liver cancer.
Yuxuan Li, Jie Zhu, Zongdong Yu, et al.
PubMed (2023) Vol. 13, Iss. 10, pp. 4832-4871
Closed Access | Times Cited: 8
Yuxuan Li, Jie Zhu, Zongdong Yu, et al.
PubMed (2023) Vol. 13, Iss. 10, pp. 4832-4871
Closed Access | Times Cited: 8
The Role of HECT-Type E3 Ligase in the Development of Cardiac Disease
Jun Goto, Yoichiro Otaki, Tetsu Watanabe, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 6065-6065
Open Access | Times Cited: 19
Jun Goto, Yoichiro Otaki, Tetsu Watanabe, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 6065-6065
Open Access | Times Cited: 19
E3 ligase HECTD3 promotes RNA virus replication and virus-induced inflammation via K33-linked polyubiquitination of PKR
Jiaying Huang, Yu Zhou, Xuelian Li, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 7
Open Access | Times Cited: 7
Jiaying Huang, Yu Zhou, Xuelian Li, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 7
Open Access | Times Cited: 7
Impaired G2/M cell cycle arrest induces apoptosis in pyruvate carboxylase knockdown MDA-MB-231 cells
Khanti Rattanapornsompong, Janya Khattiya, Phatchariya Phannasil, et al.
Biochemistry and Biophysics Reports (2021) Vol. 25, pp. 100903-100903
Open Access | Times Cited: 17
Khanti Rattanapornsompong, Janya Khattiya, Phatchariya Phannasil, et al.
Biochemistry and Biophysics Reports (2021) Vol. 25, pp. 100903-100903
Open Access | Times Cited: 17
Serum proteomic biomarker investigation of vascular depression using data-independent acquisition: a pilot study
Liuyi Lan, Sisi Peng, Ran Zhang, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 2
Liuyi Lan, Sisi Peng, Ran Zhang, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 2
Epigenetic Modifiers in Cancer Metastasis
Die Hu, Tianci Zhao, Chenxing Xu, et al.
Biomolecules (2024) Vol. 14, Iss. 8, pp. 916-916
Open Access | Times Cited: 2
Die Hu, Tianci Zhao, Chenxing Xu, et al.
Biomolecules (2024) Vol. 14, Iss. 8, pp. 916-916
Open Access | Times Cited: 2
HECTD3 promotes gastric cancer progression by mediating the polyubiquitination of c-MYC
Guanghui Zhang, Qingzong Zhu, Xiaomin Yan, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 10
Guanghui Zhang, Qingzong Zhu, Xiaomin Yan, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 10
HECTD2/TNFAIP1 Axis Regulating the p38/JNK Pathway to Promote an Inflammatory Response in Renal Cell Carcinoma Cells
DONG LV, YONGBO CHEN, Liang-you Tang, et al.
In Vivo (2024) Vol. 38, Iss. 3, pp. 1094-1103
Open Access | Times Cited: 1
DONG LV, YONGBO CHEN, Liang-you Tang, et al.
In Vivo (2024) Vol. 38, Iss. 3, pp. 1094-1103
Open Access | Times Cited: 1
Identification of PSMD2 as a promising biomarker for pancreatic cancer patients based on comprehensive bioinformatics and in vitro studies
Xiuxue Feng, Qiang Liu, Huikai Li, et al.
Heliyon (2024) Vol. 10, Iss. 22, pp. e40117-e40117
Open Access | Times Cited: 1
Xiuxue Feng, Qiang Liu, Huikai Li, et al.
Heliyon (2024) Vol. 10, Iss. 22, pp. e40117-e40117
Open Access | Times Cited: 1
HIF-1α Induces HECTD2 Up-Regulation and Aggravates the Malignant Progression of Renal Cell Cancer via Repressing miR-320a
Dong Lv, Taimin Shen, Juncheng Yao, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 10
Dong Lv, Taimin Shen, Juncheng Yao, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 10
Identification of ubiquitination-related gene classification and a novel ubiquitination-related gene signature for patients with triple-negative breast cancer
Kankan Zhao, Yuan Zheng, Wenliang Lu, et al.
Frontiers in Genetics (2023) Vol. 13
Open Access | Times Cited: 3
Kankan Zhao, Yuan Zheng, Wenliang Lu, et al.
Frontiers in Genetics (2023) Vol. 13
Open Access | Times Cited: 3
WSB1 Involvement in Prostate Cancer Progression
Laura Boldrini, Massimo Bardi
Genes (2023) Vol. 14, Iss. 8, pp. 1558-1558
Open Access | Times Cited: 2
Laura Boldrini, Massimo Bardi
Genes (2023) Vol. 14, Iss. 8, pp. 1558-1558
Open Access | Times Cited: 2
FBXL16 Promotes Endometrial Progesterone Resistance via PP2AB55α/Cyclin D1 Axis in Ishikawa
Haoen Liu, Han Li, Liyan Zhong, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 3
Haoen Liu, Han Li, Liyan Zhong, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 3
Targeting the HECTD3-p62 axis increases the radiosensitivity of triple negative breast cancer cells
Maobo Huang, Wenjing Liu, Zhuo Cheng, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access
Maobo Huang, Wenjing Liu, Zhuo Cheng, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access
Lower expression of PDZRN3 induces endometrial carcinoma progression via the activation of canonical Wnt signaling
Qiuhong Li, Jie Zhong, Shangjie Yang, et al.
Oncology Letters (2022) Vol. 23, Iss. 3
Open Access | Times Cited: 2
Qiuhong Li, Jie Zhong, Shangjie Yang, et al.
Oncology Letters (2022) Vol. 23, Iss. 3
Open Access | Times Cited: 2
HECTD3 enhances cell radiation resistance and migration by regulating LKB1 mediated ZEB1 in glioma
Jinjin Yuan, Junqi Liu, Ruitai Fan, et al.
European Journal of Neuroscience (2022) Vol. 56, Iss. 4, pp. 4275-4286
Closed Access | Times Cited: 2
Jinjin Yuan, Junqi Liu, Ruitai Fan, et al.
European Journal of Neuroscience (2022) Vol. 56, Iss. 4, pp. 4275-4286
Closed Access | Times Cited: 2
Lack of UGT polymorphism association with idasanutlin pharmacokinetics in solid tumor patients
W. Venus So, Tai-Hsien Ou Yang, Xing Yang, et al.
Cancer Chemotherapy and Pharmacology (2018) Vol. 83, Iss. 1, pp. 209-213
Open Access | Times Cited: 2
W. Venus So, Tai-Hsien Ou Yang, Xing Yang, et al.
Cancer Chemotherapy and Pharmacology (2018) Vol. 83, Iss. 1, pp. 209-213
Open Access | Times Cited: 2
